|
1
|
Chen M, Zhang W, Lee L, Saxena J, Sindher S, Chinthrajah RS, Dant C, Nadeau K. Biologic therapy for food allergy. JOURNAL OF FOOD ALLERGY 2020; 2:86-90. [PMID: 39022154 PMCID: PMC11250429 DOI: 10.2500/jfa.2020.2.200004] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 07/20/2024]
Abstract
With the rising prevalence, food allergies have become a significant health burden that affects 6% to 13% of the global population. Although oral immunotherapy (OIT) has been promising for food allergies, this therapy has limitations, including high rates of adverse reactions and long treatment periods. Biologics may address these limitations by increasing the safety and tolerability of OIT and decreasing treatment periods. The use of biologics and vaccines are actively being explored as monotherapy as well as adjunctive therapy in combination with allergen specific OIT. A number of biologics that target key molecules known to be involved in food allergy are under investigation, including anti-immunoglobulin E therapy (omalizumab), anti-interleukin (IL) 4 receptor a (dupilumab), anti-IL-5 (mepolizumab and reslizumab), and anti-IL-5R (benralizumab), anti-IL-33 (etokimab), and peanut DNA plasmid vaccines. In the era of precision medicine, the future of food allergy looks promising, and biologics will provide treatment as well as further insights into the molecular mechanisms associated with food allergy.
Collapse
Affiliation(s)
- Meng Chen
- From the Sean N. Parker Center for Allergy and Asthma Research at Stanford University, Stanford University, Stanford, California, and
- Division of Pulmonary, Allergy and Critical Care Medicine, Stanford University, Stanford, California
| | - Wenming Zhang
- From the Sean N. Parker Center for Allergy and Asthma Research at Stanford University, Stanford University, Stanford, California, and
| | - Lisa Lee
- From the Sean N. Parker Center for Allergy and Asthma Research at Stanford University, Stanford University, Stanford, California, and
| | - Jamie Saxena
- From the Sean N. Parker Center for Allergy and Asthma Research at Stanford University, Stanford University, Stanford, California, and
| | - Sayantani Sindher
- From the Sean N. Parker Center for Allergy and Asthma Research at Stanford University, Stanford University, Stanford, California, and
- Division of Pulmonary, Allergy and Critical Care Medicine, Stanford University, Stanford, California
| | - R. Sharon Chinthrajah
- From the Sean N. Parker Center for Allergy and Asthma Research at Stanford University, Stanford University, Stanford, California, and
- Division of Pulmonary, Allergy and Critical Care Medicine, Stanford University, Stanford, California
| | - Christopher Dant
- From the Sean N. Parker Center for Allergy and Asthma Research at Stanford University, Stanford University, Stanford, California, and
| | - Kari Nadeau
- From the Sean N. Parker Center for Allergy and Asthma Research at Stanford University, Stanford University, Stanford, California, and
- Division of Pulmonary, Allergy and Critical Care Medicine, Stanford University, Stanford, California
| |
Collapse
|